The effect of membrane-fluidizing agents on sodium-pump activity in erythrocytes [proceedings].
D001557:Benzenesulfonates / Q000494:pharmacology; D001592:Benzyl Alcohols / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D002784:Cholesterol / Q000097:blood*; D004910:Erythrocyte Membrane / Q000378:metabolism*; D004912:Erythrocytes / Q000378:metabolism*; D006801:Humans; D007099:Imipramine / Q000494:pharmacology; D007473:Ion Channels / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D008560:Membrane Fluidity / Q000187:drug effects; D008563:Membrane Lipids / Q000097:blood*; D009829:Oleic Acids / Q000494:pharmacology; D012964:Sodium / Q000097:blood*; D014783:Viscosity
D001557:Benzenesulfonates; D001592:Benzyl Alcohols; D007473:Ion Channels; D008563:Membrane Lipids; D009829:Oleic Acids; D002784:Cholesterol; D012964:Sodium; D007099:Imipramine; D002746:Chlorpromazine